Pujol, E.; Zarei, M.; Pizarro, J.; Loza, M.a.I.; Brea, J.M.; Vázquez-Carrera, M.; Vázquez, S.
New Diarylureas as Activators of the Heme-Regulated EIF2α Kinase for the Treatment of Type 2 Diabetes Mellitus. Proceedings 2019, 22, 19.
https://doi.org/10.3390/proceedings2019022019
AMA Style
Pujol E, Zarei M, Pizarro J, Loza MaI, Brea JM, Vázquez-Carrera M, Vázquez S.
New Diarylureas as Activators of the Heme-Regulated EIF2α Kinase for the Treatment of Type 2 Diabetes Mellitus. Proceedings. 2019; 22(1):19.
https://doi.org/10.3390/proceedings2019022019
Chicago/Turabian Style
Pujol, Eugènia, Mohammad Zarei, Javier Pizarro, M aria Isabel Loza, José Manuel Brea, Manuel Vázquez-Carrera, and Santiago Vázquez.
2019. "New Diarylureas as Activators of the Heme-Regulated EIF2α Kinase for the Treatment of Type 2 Diabetes Mellitus" Proceedings 22, no. 1: 19.
https://doi.org/10.3390/proceedings2019022019
APA Style
Pujol, E., Zarei, M., Pizarro, J., Loza, M. a. I., Brea, J. M., Vázquez-Carrera, M., & Vázquez, S.
(2019). New Diarylureas as Activators of the Heme-Regulated EIF2α Kinase for the Treatment of Type 2 Diabetes Mellitus. Proceedings, 22(1), 19.
https://doi.org/10.3390/proceedings2019022019
